Rights and permissions
About this article
Cite this article
High-dose atorvastatin decreases risk of cardiovascular events in coronary bypass patients. Inpharma Wkly. 1640, 19 (2008). https://doi.org/10.2165/00128413-200816400-00042
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816400-00042